Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KTTA

Pasithea Therapeutics Corp

Jun 11 • 04:00PM ET

0.6080

+0.0278 4.79 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: BCTX CLRB JSPR LGVN MRKR NXTC PLUR TPST TRAW VTGN

| Held by: PSIL VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.07	Insider Own	11.37%	Shs Outstand	33.41M	Perf Week	-1.92%
Market Cap	20.32M	Forward P/E	-	EPS next Y	-1.01	Insider Trans	0.00%	Shs Float	29.62M	Perf Month	-22.06%
Enterprise Value	-30.18M	PEG	-	EPS next Q	-0.16	Inst Own	52.61%	Short Float	0.93%	Perf Quarter	-26.51%
Income	-19.73M	P/S	-	EPS this Y	73.88%	Inst Trans	-2.66%	Short Ratio	0.55	Perf Half Y	-48.03%
Sales	0.00M	P/B	0.28	EPS next Y	-32.89%	ROA	-55.58%	Short Interest	0.27M	Perf YTD	-52.87%
Book/sh	2.20	P/C	0.40	EPS next 5Y	23.55%	ROE	-58.22%	52W High	2.06 -70.49%	Perf Year	-28.39%
Cash/sh	1.51	P/FCF	-	EPS past 3/5Y	35.92% -117.71%	ROIC	-36.00%	52W Low	0.28 116.37%	Perf 3Y	-93.55%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.51% 7.10%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	80.42%	Oper. Margin	-	ATR (14)	0.05	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	35.40	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	35.41	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	35.40	EPS Q/Q	92.68%	SMA20	-10.06%	Beta	0.27	Target Price	3.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-16.03%	Rel Volume	0.25	Prev Close	0.58
Employees	5	LT Debt/Eq	0.00	Earnings	Jun 03	SMA200	-25.18%	Avg Volume	502.60K	Price	0.61
IPO	Sep 15, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	0.00% -	Trades		Volume	127,484	Change	4.79%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)